These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 12243493

  • 1. Pharmacodynamics of mycophenolate mofetil after heart transplantation: new mechanisms of action and correlations with histologic severity of graft rejection.
    Barten MJ, van Gelder T, Gummert JF, Boeke K, Shorthouse R, Billingham ME, Morris RE.
    Am J Transplant; 2002 Sep; 2(8):719-32. PubMed ID: 12243493
    [Abstract] [Full Text] [Related]

  • 2. Sustained suppression of peripheral blood immune functions by treatment with mycophenolate mofetil correlates with reduced severity of cardiac allograft rejection.
    Klupp J, van Gelder T, Dambrin C, Regieli JJ, Boeke K, Billingham ME, Morris RE.
    J Heart Lung Transplant; 2004 Mar; 23(3):334-51. PubMed ID: 15019644
    [Abstract] [Full Text] [Related]

  • 3. Pharmacodynamics of mycophenolic acid in heart allograft recipients: correlation of lymphocyte proliferation and activation with pharmacokinetics and graft histology.
    Gummert JF, Barten MJ, van Gelder T, Billingham ME, Morris RE.
    Transplantation; 2000 Oct 15; 70(7):1038-49. PubMed ID: 11045640
    [Abstract] [Full Text] [Related]

  • 4. Novel assays of multiple lymphocyte functions in whole blood measure: new mechanisms of action of mycophenolate mofetil in vivo.
    Barten MJ, van Gelder T, Gummert JF, Shorthouse R, Morris RE.
    Transpl Immunol; 2002 Jun 15; 10(1):1-14. PubMed ID: 12182459
    [Abstract] [Full Text] [Related]

  • 5. Mycophenolate mofetil pharmacodynamics and pharmacokinetics correlate with rejection score in a BN-to-LEW heterotopic heart transplant model.
    Klupp J, van Gelder T, Dambrin C, Regieli J, Boeke K, Billingham ME, Morris RE.
    Transplant Proc; 2001 May 15; 33(3):2170-1. PubMed ID: 11377490
    [No Abstract] [Full Text] [Related]

  • 6. Synergistic effects of mycophenolate mofetil and sirolimus in prevention of acute heart, pancreas, and kidney allograft rejection and in reversal of ongoing heart allograft rejection in the rat.
    Vu MD, Qi S, Xu D, Wu J, Peng J, Daloze P, Sehgal S, Leduc B, Chen H.
    Transplantation; 1998 Dec 27; 66(12):1575-80. PubMed ID: 9884242
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Mycophenolic mofetil optimized pharmacokinetic modelling, and exposure-effect associations in adult heart transplant recipients.
    Woillard JB, Saint-Marcoux F, Monchaud C, Youdarène R, Pouche L, Marquet P.
    Pharmacol Res; 2015 Sep 27; 99():308-15. PubMed ID: 26192348
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. New mechanisms of action of mycophenolate mofetil in transplant recipients by assessment of its pharmacodynamics.
    Barten MJ, van Gelder T, Gummert JF, Shorthouse R, Boeke K, Billingham ME, Morris RE.
    Transplant Proc; 2001 May 27; 33(3):2254-5. PubMed ID: 11377519
    [No Abstract] [Full Text] [Related]

  • 12. The pharmacokinetics of mycophenolate mofetil in Thai kidney transplant recipients.
    Jirasiritham S, Sumethkul V, Mavichak V, Na-Bangchang K.
    Transplant Proc; 2004 Sep 27; 36(7):2076-8. PubMed ID: 15518751
    [Abstract] [Full Text] [Related]

  • 13. Mycophenolate mofetil in cardiac transplantation.
    Kobashigawa JA.
    Curr Opin Cardiol; 1998 Mar 27; 13(2):117-21. PubMed ID: 9593551
    [Abstract] [Full Text] [Related]

  • 14. Mycophenolic acid concentrations are associated with cardiac allograft rejection.
    DeNofrio D, Loh E, Kao A, Korecka M, Pickering FW, Craig KA, Shaw LM.
    J Heart Lung Transplant; 2000 Nov 27; 19(11):1071-6. PubMed ID: 11077224
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Combination therapy of mycophenolate mofetil and rapamycin in prevention of chronic renal allograft rejection in the rat.
    Jolicoeur EM, Qi S, Xu D, Dumont L, Daloze P, Chen H.
    Transplantation; 2003 Jan 15; 75(1):54-9. PubMed ID: 12544871
    [Abstract] [Full Text] [Related]

  • 17. Best single time points as surrogates to the tacrolimus and mycophenolic acid area under the curve in adult liver transplant patients beyond 12 months of transplantation.
    Mardigyan V, Tchervenkov J, Metrakos P, Barkun J, Deschenes M, Cantarovich M.
    Clin Ther; 2005 Apr 15; 27(4):463-9. PubMed ID: 15922819
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.